BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9625823)

  • 1. Clinicopathologic and immunohistochemical analyses in lung metastasis of colorectal carcinoma.
    Koshiji M; Ogura E; Takada H; Kawanishi H; Ikehara S; Hioki K
    Oncol Rep; 1998; 5(4):811-5. PubMed ID: 9625823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum carcinoembryonic antigen levels and proliferating cell nuclear antigen labeling index for patients with colorectal carcinoma. Correlation with tumor progression and survival.
    Nakamura T; Tabuchi Y; Nakae S; Ohno M; Saitoh Y
    Cancer; 1996 Apr; 77(8 Suppl):1741-6. PubMed ID: 8608572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoembryonic antigen and carbohydrate antigen 19-9 levels of peripheral and draining venous blood in colorectal cancer patients. Correlation with histopathologic and immunohistochemical variables.
    Tabuchi Y; Deguchi H; Saitoh Y
    Cancer; 1988 Oct; 62(8):1605-13. PubMed ID: 3167774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunohistochemical detection of proliferating cell nuclear antigen (PCNA) in carcinoma at the confluence of the main hepatic ducts and its relationship to expression of CEA, CA19-9 and EGF receptor].
    Kawamoto T; Saitou K; Todoroki T; Koike N; Kanazawa N; Iwasaki Y; Nakamura K
    Nihon Shokakibyo Gakkai Zasshi; 1993 Feb; 90(2):144-53. PubMed ID: 8096556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
    Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
    Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoembryonic antigen staining patterns at the invasive tumor margin predict the malignant potential of colorectal carcinoma.
    Teixeira CR; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
    Oncology; 1994; 51(3):228-33. PubMed ID: 7515172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new cell proliferating marker: cytosolic thymidine kinase as compared to proliferating cell nuclear antigen in patients with colorectal carcinoma.
    Wu J; Mao Y; He L; Wang N; Wu C; He Q; Skog S
    Anticancer Res; 2000; 20(6C):4815-20. PubMed ID: 11205225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of serum carbohydrate antigen 19-9 for predicting extrahepatic metastasis in patients with liver metastasis from colorectal carcinoma.
    Sasaki A; Kawano K; Inomata M; Shibata K; Matsumoto T; Kitano S
    Hepatogastroenterology; 2005; 52(66):1814-9. PubMed ID: 16334783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?
    Chen CC; Yang SH; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC
    J Surg Res; 2005 Apr; 124(2):169-74. PubMed ID: 15820244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivin isoforms and clinicopathological characteristics in colorectal adenocarcinomas using real-time qPCR.
    Pavlidou A; Dalamaga M; Kroupis C; Konstantoudakis G; Belimezi M; Athanasas G; Dimas K
    World J Gastroenterol; 2011 Mar; 17(12):1614-21. PubMed ID: 21472129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of carcinoembryonic antigen and biologic behavior in colorectal carcinoma.
    Kim JC; Han MS; Lee HK; Kim WS; Park SK; Park KC; Bodmer WF; Rowan AJ; Kim OJ
    Dis Colon Rectum; 1999 May; 42(5):640-8. PubMed ID: 10344687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of prognostic factors and PCNA expression for pulmonary metastatic tumors of colorectal carcinoma.
    Matsushima S; Yamamoto H; Suzuki S; Egami K; Yoshioka M; Yamada N; Tanaka S
    J Nippon Med Sch; 2000 Feb; 67(1):28-31. PubMed ID: 10777845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer.
    Hiraga Y; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F; Kohno N
    Oncology; 1998; 55(4):307-19. PubMed ID: 9663420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of CEA and CA19-9 combination as a prognostic indicator and for recurrence monitoring in patients with stage II colorectal cancer.
    Shibutani M; Maeda K; Nagahara H; Ohtani H; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Ohira M; Hirakawa K
    Anticancer Res; 2014 Jul; 34(7):3753-8. PubMed ID: 24982398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
    Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
    J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristic differences between patients who have undergone surgical treatment for lung metastasis or hepatic metastasis from colorectal cancer.
    Iwasaki A; Shirakusa T; Yamashita Y; Noritomi T; Maekawa T; Hamada T
    Thorac Cardiovasc Surg; 2005 Dec; 53(6):358-64. PubMed ID: 16311973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical study of colorectal adenocarcinomas and adenomas with antibodies against carcinoembryonic antigen (CEA), CA19-9, keratin, alpha-tubulin and secretory component (SC).
    Taguchi T; Kijima H; Mitomi T; Osamura RY
    Gastroenterol Jpn; 1991 Jun; 26(3):294-302. PubMed ID: 1716231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and characterization of a new human lung poorly differentiated adenocarcinoma cell line, GLL-1, producing carcinoembryonic antigen (CEA) and CA19-9.
    Mitsuhashi N; Takahashi T; Sakurai H; Yamakawa M; Hasegawa M; Furuta M; Matsumoto H; Higuchi K; Hayakawa K; Niibe H
    Lung Cancer; 1995 Mar; 12(1-2):13-24. PubMed ID: 7600027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlationship between proliferating cell nuclear antigen (PCNA) expression and clinicopathological factors in colorectal cancer].
    Shirono J; Nakamura T; Nakae S; Saito Y
    Nihon Geka Gakkai Zasshi; 1995 Dec; 96(12):787-91. PubMed ID: 8587571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.